Axillary assessment in breast cancer patients Cancer
Conditions
Interventions
Accuracy of axillary ultrasound (US) in diagnosing metastatic lymph nodes in breast cancer patients
US will be performed on breast cancer patients to assess lymph node status using predetermined cri
lobulated or irregular margin
cortical changes, such as diffuse cortical thickness = 3 mm, focal cortical thickness = 3 mm, or markedly hypoechoic cortex
and sinus changes, such as displacement or total replacement, in addition to nonhilar blood flow displayed by color Doppler sonography. Then, these dimensional and morphological criteria are recorded.
Sponsors
Hawler Medical University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women with histologically confirmed breast cancer
Exclusion criteria
Exclusion criteria: 1. A prior diagnosis of breast cancer who had undergone any type of neoadjuvant treatment or surgical procedure 2. Breast cancer patients planned for neoadjuvant chemotherapy 3. History of lymphoma or other malignancies 4. Pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evidence of any breast lesion and its features, location, and dimensions measured using ultrasound versus histopathology at one timepoint | — |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy (sensitivity, specificity, positive predictive value, negative predictive value) of diagnosing metastatic lymph nodes measured using axillary ultrasound at one timepoint | — |
Countries
Iraq
Contacts
Public ContactAska Faruq Jamal
Outcome results
None listed